Table 3 Prognostic value of RABEX-5 mRNA expression for the overall survival in univariate and multivariate analyses by Cox regression
From: Expression of RABEX-5 and its clinical significance in prostate cancer
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
Covariant | Exp (B) | 95% CI | P value | Exp (B) | 95% CI | P value |
RABEX-5 mRNA expression | 1.629 | 1.038-2.555 | 0.034 | 1.751 | 1.098-2.792 | 0.019 |
Gleason score | 2.526 | 1.788-3.568 | <0.001 | 1.953 | 1.370-2.784 | <0.001 |
Preoperative PSA | 2.034 | 1.338-23.092 | 0.001 | 2.025 | 1.313-3.123 | 0.001 |
PCa Stage | 4.131 | 2.888-5.911 | <0.001 | 4.094 | 2.773-6.043 | <0.001 |
Age | 1.282 | 0.917-1.792 | 0.146 | |||
Angiolymphatic invasion | 1.373 | 0.813-2.319 | 0.235 | |||
Surgical margin status | 1.101 | 0.703-1.724 | 0.674 | |||
Lymph node metastasis | 1.044 | 0.746-1.462 | 0.800 | |||
Seminal vesicle invasion | 1.358 | 0.956-1.928 | 0.087 | |||